Keros Therapeutics shares owned by UBS O'Connor
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by UBS O'Connor
from 13F filings
Historical chart of UBS O'Connor investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by UBS O'Connor
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $506k | 38k | 13.35 |
| 2025-03-31 | $1.2M | 116k | 10.19 |
| 2024-12-31 | $806k | 51k | 15.83 |
| 2024-09-30 | $1.4M | 25k | 58.07 |
| 2024-03-31 | $1.1M | 17k | 66.20 |
| 2023-09-30 | $1.9M | 60k | 31.88 |
| 2023-06-30 | $2.2M | 55k | 40.18 |
| 2023-03-31 | $1.9M | 46k | 42.70 |
| 2022-12-31 | $2.2M | 45k | 48.02 |
| 2022-09-30 | $1.3M | 33k | 37.63 |
| 2022-06-30 | $1.6M | 57k | 27.63 |
| 2022-03-31 | $1.4M | 25k | 54.40 |